scholarly journals Sustained low-efficiency diafiltration is superior to hemodialysis in promoting renal function recovery in elderly wasp sting victims with stage III acute kidney injury: a retrospective study

Renal Failure ◽  
2019 ◽  
Vol 41 (1) ◽  
pp. 814-820 ◽  
Author(s):  
Yan-Yan Deng ◽  
Jian-Ming Shen ◽  
Ya-Ni Mao ◽  
Rong Gou ◽  
Wen-Wen Li ◽  
...  
2018 ◽  
Vol 52 (1) ◽  
pp. 86-89 ◽  
Author(s):  
Eduardo C. Gomes ◽  
Diego R. Falci ◽  
Pedro Bergo ◽  
Alexandre P. Zavascki ◽  
Maria Helena Rigatto

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Chien-Ning Hsu ◽  
You-Lin Tain

Abstract Background and Aims Renal function recovery after acute kidney injury (AKI) is associated with patient outcomes. The study objectives were to assess the patterns of AKI recovery within 6 months following discharge for AKI and subsequent incidence of chronic dialysis. Method A retrospective cohort of 234,867 hospitalized adult patients was examined for AKI between January 1, 2010, and December 31, 2017 in the largest healthcare delivery system in Taiwan. Renal function recovery at 3- and 6-month post discharge, incident chronic kidney disease and chronic dialysis initiation were analyzed over 7 years of follow-up. Renal recovery was defined by < 1.5× baseline SCr (prior to the hospitalization). Independent associations between renal function recovery patterns and renal outcomes was assessed by Cox proportional hazard model controlling for potential confounders, and subdistribution hazard ratio (SHR) with [95% CI] was analysed for competing risk of early death. Results Among 3 months AKI survivors (n=24,132), 14.28% (n=3,430) did not recovery back to baseline, and 16% of recovery did not sustain. Three distinct renal function recovery continuums at 6 months post hospital discharge were: persistent non-recovery (10.18%), non-recovery (14.33%), and recovery (75.5%). Comparing to survivors without AKI (n=50,387), the impact of renal recovery continuum on chronic dialysis initiation varied by patient’s baseline renal disease (SHR was 2.82 [95%CI, 2.42-3.28] in CKD, and 0.8 [95%CI, 0.27-2.38] for non-CKD. Persistent non-recovery was significantly associated with a greater increased risk of chronic dialysis than non-recovery in any patients with AKI. Comparing to patients with sustained AKI recovery, risk of CKD onset increased 5-fold in persistent non-recovery and 3-fold risk in non-recovery. Conclusion The continuum of AKI recovery post 6 months is associated with increased risk of chronic dialysis, particularly in patients with baseline CKD. These study results suggested that patients ever with AKI should receive close renal function monitoring for post-discharge management.


2019 ◽  
Vol 248 (2) ◽  
pp. 63-71 ◽  
Author(s):  
Zorica M. Dimitrijevic ◽  
Sonja S. Salinger-Martinovic ◽  
Radmilo J. Jankovic ◽  
Branka P. Mitic

2017 ◽  
Vol 5 ◽  
pp. 2050313X1770505 ◽  
Author(s):  
James Harms ◽  
Ayaz Khawaja ◽  
Maria Taylor ◽  
Xiaosi Han ◽  
Michal Mrug

Objectives: This case report describes two cases of high-dose methotrexate–induced nephrotoxicity: death in the case of conventional supportive care and successful renal function recovery in a patient treated with glucarpidase and continuous dialysis. Methods: High dose methotrexate is widely used for management of adult and pediatric malignancies. However, high-dose methotrexate–induced renal nephrotoxicity may cause severe, even lethal complications. Here we present examples of such outcomes. Results: We present one case of lethal high-dose methotrexate nephrotoxicity in a patient treated with conventional rescue therapy. We contrast this outcome with another patient with high-dose methotrexate–induced anuric acute kidney injury, who has recovered renal function following therapy with glucarpidase and continuous dialysis. Conclusions: This is only the second reported case of high-dose methotrexate–induced anuric acute kidney injury, and the only one with a reported clinical outcome. This first report of recovery from high-dose methotrexate–induced anuric acute kidney injury after glucarpidase administration supports available evidence pointing to the effectiveness of this therapy.


2012 ◽  
Vol 34 (4) ◽  
pp. 337-342 ◽  
Author(s):  
Ginivaldo Victor Ribeiro do Nascimento ◽  
André Luis Balbi ◽  
Daniela Ponce ◽  
Juliana Maria Gera Abrão

2011 ◽  
Vol 20 (8) ◽  
pp. 1193-1208 ◽  
Author(s):  
Gaetano La Manna ◽  
Francesca Bianchi ◽  
Maria Cappuccilli ◽  
Giovanna Cenacchi ◽  
Lucia Tarantino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document